CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | RICHMAN ERIC I Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2019-03-13 | Fong Bryant Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2019-02-11 | PERCEPTIVE ADVISORS LLC 10% owner | Purchase · Warrants (right to buy) | +1,360,000 | 1,360,000 | ||
| 2019-01-23 | LENZ BRIAN EVP, CFO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-01-23 | Mond James EVP, CSO and CMO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-01-23 | Grossman Adam S President and CEO | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2018-06-22 | Fong Bryant Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-22 | RICHMAN ERIC I Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-22 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-22 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-22 | Guiheen Lawrence P. Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-22 | Grossman Jerrold B Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-06-08 | Grossman Jerrold B Director | Purchase | +20,921 | $4.78 | $100K | 98,007 |
| 2018-06-08 | Grossman Jerrold B Director | Purchase | +31,381 | $4.78 | $150K | 31,381 |
| 2018-06-08 | Grossman Adam S President and CEO | Purchase | +20,921 | $4.78 | $100K | 32,527 |
| 2018-06-08 | Grossman Adam S President and CEO | Purchase | +52,301 | $4.78 | $250K | 796,301 |
| 2018-06-08 | Guiheen Lawrence P. Director | Purchase | +20,000 | $4.78 | $96K | 25,000 |
| 2018-06-08 | LENZ BRIAN VP, CFO | Purchase | +5,000 | $4.78 | $24K | 20,000 |
| 2018-06-08 | RICHMAN ERIC I Director | Purchase | +5,230 | $4.78 | $25K | 36,530 |
| 2018-05-14 | Biotest Divestiture Trust 10% owner | Sale | −8,591,160 | 0 |
Page 23 of 31 · 618 trades